MacroGenics
MGNX
#8653
Rank
S$0.30 B
Marketcap
S$4.77
Share price
-7.73%
Change (1 day)
123.13%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of March 2026 : S$27.33 Million

According to MacroGenics's latest financial reports the company has S$27.33 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$S$71.37 M-54.76%
2024-12-31$S$0.15 B-21.73%
2023-12-31$S$0.20 B5.87%
2022-12-31$S$0.19 B-41.23%
2021-12-31$S$0.32 B-17.24%
2020-12-31$S$0.39 B25.89%
2019-12-31$S$0.31 B-6.29%
2018-12-31$S$0.33 B-17.1%
2017-12-31$S$0.40 B2.9%
2016-12-31$S$0.38 B-12.24%
2015-12-31$S$0.44 B176.57%
2014-12-31$S$0.16 B60.29%
2013-12-31$S$99.98 M-1092.54%
2012-12-31$-S$10.08 Million-55.51%
2011-12-31$-S$22.65 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
S$116.58 B 426,374.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$40.23 B 147,074.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.85 B 43,253.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$30.21 B 110,434.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$59.23 B 216,576.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$25.92 B 94,729.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.66 B 2,332.46%๐Ÿ‡บ๐Ÿ‡ธ USA